Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers report details of new studies and findings in the area of breast cancer
November 18th, 2005
Breast cancer data are the focus of recent research from the United States, b and United Kingdom. Study 1: Aromatase inhibitors appear more effective than tamoxifen at preventing breast cancer, however, more trials are needed to answer important questions regarding treatments. "Endocrine therapy of hormone receptor-positive breast tumors is widely used as palliative therapy for metastatic breast cancer and as adjuvant therapy for early stage breast cancer," according to researchers from the United States. "Tamoxifen has been the definitive standard of hormonal therapies for the last 30 years because of its documented efficacy and reasonable safety...
Source: Drug Week (2005-11-18)
|
